Semaglutide is primarily prescribed for two groups of people: People with Type 2 Diabetes: For these individuals, semaglutide helps manage blood sugar levels and reduce the risk of complications, such as heart disease, kidney problems, and nerve damage
By introducing ozone therapy early in the treatment process, caretakers and veterinarians can interrupt this inflammatory cascade before more serious damage occurs
It's a new way to access GLP-1 treatment in a format that may feel more familiar, with studies showing weight loss outcomes comparable to Wegovy injections
Starting doses vary by product: semaglutide typically starts at 0.25 mg weekly, dulaglutide at 0.75 mg weekly, tirzepatide at 2.5 mg weekly, while liraglutide begins at 0.6 mg daily
Whilst its classical role involves stimulating insulin secretion in response to food intake, emerging research has revealed that GLP-1 exerts significant effects beyond glucose regulation